Available Technologies   //   Invention Disclosure

Tech at Polsky

BACK TO SEARCH RESULTS

Hydrocarbon-Stapled Peptides To Inhibit SARS-CoV-2 Viral Infection

Inventor(s):

Technology Classifications > Therapeutics Technology Classifications > SARS-CoV-2

    SUMMARY

    • The SARS-CoV-2 virus spreads by binding its spike protein to the human angiotensin-converting enzyme 2 (hACE2) protein expressed at the cell surface of lungs, arteries, heart, kidney, and intestines.
    • The inventors have developed 12 hydrocarbon stapled peptides that bind to the viral spike protein.  Delivered by nanoparticles, these peptides mimic the human ACE2 receptor, which SARS-CoV-2’s spike protein binds to in order to enter the host cell.
    • Their single and double-stapled hydrocarbon peptides maintain their secondary shape at a wide range of biologically relevant temperatures. They inhibit binding and entry of the SARS-CoV-2 virus through molecular mimicry. 
    • The inventors aim to further develop hydrocarbon-stapled peptides as intravenous and nebulized nanocarriers for COVID-19 drugs. 

    FIGURE

    A) Structural interaction between the SARS-CoV-2’s spike protein Receptor Binding Domain (RBD) and the 𝛼1 helix of the ACE2 protein.  B) Protein-Protein Interaction (PPI) of SARS-CoV-2-ACE2 stapled hydrocarbons.  RBD residues are shown in red and highlighted in the stapled alpha helical peptides (SAHPs) of the 𝛼1 helix. Hydrocarbon-stapled RBD residues at positions i, (i+4) are shown in blue.

    ADVANTAGES

    ADVANTAGES

    • Addresses protein-protein interaction (PPI) between RBD and hACE2 to directly inhibit SARS-CoV-2 viral infection.
    • Superior bioavailability, proteolytic resistance, and target cell delivery compared to current COVID-19 therapeutic options.
    • Hydrocarbon-staple packaging based on previous breakthroughs with peptide amphiphile (PA) and polymersome nanoparticles. 

    APPLICATIONS

    • SARS-CoV-2

    TECH DETAILS

    Published
    12/15/2021

    Reference ID
    21-T-050

    Have Questions?

    Michael Hinton

    Contact Michael Hinton, Manager, Technology Marketing, who can provide more detail about this technology, discuss the licensing process, and connect you with the inventor.

    This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

    Accept
    [%Analytics%]